Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Protara Therapeutics Inc (TARA)

109 + Investors. Track Smart Money conviction in TARA. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +8
Streak
4Q ▲
Buyers last Q
62%

Smart Money Signals — TARA

Based on 110 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q
For 4 consecutive quarters, more hedge funds added TARA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
110 hedge funds hold TARA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +86% more funds vs a year ago

fund count last 6Q
+51 new funds entered over the past year (+86% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 62% buying

76 buying47 selling
Last quarter: 76 funds were net buyers (31 opened a brand new position + 45 added to an existing one). Only 47 were sellers (24 trimmed + 23 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~31 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 25 → 13 → 32 → 31. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
📌

Mixed — 25% long-term, 38% new

■ 25% conviction (2yr+) ■ 37% medium ■ 38% new
Of the 110 current holders: 27 (25%) held >2 years, 41 held 1–2 years, and 42 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
🚀

Acceleration phase — new buyers rushing in

10 → 25 → 13 → 32 → 31 new funds/Q
New funds entering each quarter: 25 → 13 → 32 → 31. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 41% veterans vs 39% newcomers

■ 41% veterans ■ 19% 1-2yr ■ 39% new
Entry-cohort mix of 114 holders: 47 (41%) are 2+ year veterans, 22 entered 1–2 years ago, and 45 (39%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 36% AUM from major funds

36% from top-100 AUM funds
31 of 110 holders rank in the top 100 by AUM, accounting for 36% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.9
out of 10
Moderate Exit Risk
Exit risk score 4.9/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TARA

In 2026 Q1, 76 hedge funds were net buyers of TARA (31 opened a new position, 45 added to an existing one), while 47 reduced or exited (24 trimmed, 23 sold completely) — a 62% buyer ratio, indicating clear institutional accumulation. This marks 4 consecutive quarters of net institutional buying — a persistent conviction signal. 36% of total institutional value in TARA is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +8 funds (more new holders than closures). Total institutional holders: 110.

Hedge Fund Ownership: TARA

How many hedge funds hold TARA — quarterly history vs. share price
Quarterly hedge fund ownership of TARA vs. share price

Market Analysis: TARA

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TARA

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Protara Therapeutics Inc (TARA) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much TARA has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 81d ago
TARA
-23.6%
XLV
+2.1%

TARA outperformed XLV by -25.7% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 36d ago
TARA
-22.0%
XLV
+3.2%

Since the filing became public, TARA outperformed XLV by -25.2% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

13 top-rated funds 1 high-conviction
Consensus
5.0
/ 10
breadth
×
Elite
1.7
/ 10
conviction
Hedge Fund Positioning: TARA
109 + Investors

Track Smart Money conviction in TARA. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 109 102 6.86%
13F Shares 46M 40M 14.39%
Total Value $238M $213M 11.79%
New Positions 30 32 -2
Increased Positions 45 44 +1
Closed Positions 23 9 +14
Reduced Positions 22 15 +7
Total Calls 2 3 -33.33%
Total Puts 2 1 100.0%
PUT/CALL Ratio 1.0 0.33 Neutral

Statistics: TARA

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

109 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TARA. Verified SEC 13F-HR filings.

QUARTER:
Top 25 TARA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Velan Capital Investment Management LP 9.25% 2,834,652 $14.8M
2 Acorn Capital Advisors, LLC 2.59% 1,752,115 $9.1M
3 5AM Venture Management, LLC 1.98% 1,369,782 $7.1M
4 Sio Capital Management, LLC 1.47% 1,969,839 $10.3M
5 AIGH Capital Management LLC 1.15% 1,622,733 $8.5M
6 Patient Square Capital LP 0.95% 1,030,846 $5.4M
7 Catalio Capital Management, LP 0.63% 580,024 $3.0M
8 Superstring Capital Management LP 0.45% 121,457 $633K
9 Integral Health Asset Management, LLC 0.44% 1,750,000 $9.1M
10 ADAR1 Capital Management, LLC 0.29% 940,512 $4.9M
11 Nano Cap New Millennium Growth Fund L P 0.18% 36,500 $190K
12 J. Goldman & Co LP 0.13% 856,247 $4.5M
13 Burkehill Global Management, LP 0.12% 450,000 $2.3M
14 Blackstone Inc. 0.05% 2,265,514 $11.8M
15 Fox Run Management, L.L.C. 0.03% 35,965 $174K
16 Baker BROS. Advisors LP 0.03% 971,614 $5.1M
17 Almanack Investment Partners, LLC. 0.02% 23,782 $124K
18 Essential Partners LLC 0.02% 9,872 $51K
19 Janus Henderson Group plc 0.01% 5,207,011 $27.2M
20 Oppenheimer & Co Inc 0.01% 181,565 $946K
21 Walleye Capital LLC 0.01% 443,401 $2.3M
22 Axq Capital, LP 0.01% 13,002 $68K
23 Point72 Asset Management, L.P. 0.01% 1,152,714 $6.0M
24 Bridgeway Capital Management, LLC 0.01% 70,330 $366K
25 Millennium Management LLC 0.01% 2,831,208 $14.8M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Protara Therapeutics Inc (TARA)

What does the Smart Money Trend signal show for TARA?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added TARA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for TARA?

More buyers than sellers — 62% buying: Last quarter: 76 funds were net buyers (31 opened a brand new position + 45 added to an existing one). Only 47 were sellers (24 trimmed + 23 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for TARA holders?

Strong quality — 36% AUM from major funds: 31 of 110 holders rank in the top 100 by AUM, accounting for 36% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held TARA?

Mixed — 25% long-term, 38% new: Of the 110 current holders: 27 (25%) held >2 years, 41 held 1–2 years, and 42 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Protara Therapeutics Inc (TARA) following the 2026 Q1 hedge fund 13F filings?

As of today, TARA has moved -22.0% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of -25.2%. Since the quarter end (March 31, 2026), TARA has gained -23.6% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →